CBSTQ (Cannabist Company Holdings) Equity-to-Asset: -0.28 (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cannabist Company Holdings Equity-to-Asset?

Cannabist Company Holdings CBSTQ -99.89% Equity-to-Asset is -0.28 as of Sep. 2025. The stock has 3 warning signs investors should review. Among 1,006 Drug Manufacturers companies, Cannabist Company Holdings ranks worse than 93.74% on this metric.

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cannabist Company Holdings's Total Stockholders Equity for the quarter that ended in Sep. 2025 was $-151.7 Mil. Cannabist Company Holdings's Total Assets for the quarter that ended in Sep. 2025 was $536.5 Mil. Therefore, Cannabist Company Holdings's Equity to Asset Ratio for the quarter that ended in Sep. 2025 was -0.28.

The historical rank and industry rank for Cannabist Company Holdings's Equity-to-Asset or its related term are showing as below:

CBSTQ' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.28   Med: 0.21   Max: 0.8
Current: -0.28

During the past 7 years, the highest Equity to Asset Ratio of Cannabist Company Holdings was 0.80. The lowest was -0.28. And the median was 0.21.

CBSTQ's Equity-to-Asset is ranked worse than
93.74% of 1006 companies
in the Drug Manufacturers industry
Industry Median: 0.61 vs CBSTQ: -0.28

Cannabist Company Holdings  (OTCPK:CBSTQ) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Cannabist Company Holdings Equity-to-Asset Related Terms


Cannabist Company Holdings Equity-to-Asset Historical Data

* Premium members only.

The historical data trend for Cannabist Company Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabist Company Holdings Equity-to-Asset Chart

Cannabist Company Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Equity-to-Asset
Get a 7-Day Free Trial 0.42 0.42 0.21 0.08 -0.04

Cannabist Company Holdings Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 -0.04 -0.09 -0.25 -0.28

CBSTQ vs OWPC, AYURF, PNXP: Equity-to-Asset Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabist Company Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabist Company Holdings Equity-to-Asset vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabist Company Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Cannabist Company Holdings's Equity-to-Asset falls into.



Cannabist Company Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Cannabist Company Holdings's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Equity to Asset (A: Dec. 2024 )=Total Stockholders Equity/Total Assets
=-28.694/696.173
=-0.04

Cannabist Company Holdings's Equity to Asset Ratio for the quarter that ended in Sep. 2025 is calculated as

Equity to Asset (Q: Sep. 2025 )=Total Stockholders Equity/Total Assets
=-151.683/536.509
=-0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Equity-to-Asset →
What does a Equity-to-Asset of -0.28 mean?
Cannabist Company Holdings (CBSTQ) has a Equity-to-Asset of -0.28 as of Sep. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Cannabist Company Holdings and its competitors. According to the industry distribution chart, Cannabist Company Holdings ranks #943 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 93.7%.
Is Cannabist Company Holdings' Equity-to-Asset too high?
Cannabist Company Holdings' current Equity-to-Asset is -0.28. Based on the distribution chart, Cannabist Company Holdings ranks #943 out of 1006 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Cannabist Company Holdings' Equity-to-Asset compare to OWPC and AYURF?
According to the Drug Manufacturers industry distribution chart, Cannabist Company Holdings ranks #943 out of 1006 companies for Equity-to-Asset. This places Cannabist Company Holdings in the lower half of its industry. The industry median Equity-to-Asset is 0.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.61, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Cannabist Company Holdings and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabist Company Holdings's current Equity-to-Asset is -0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabist Company Holdings stock overvalued right now?
Based on GuruFocus' analysis, Cannabist Company Holdings (CBSTQ) is currently considered Possible Value Trap. The stock's GF Value™ is $0.15, compared to a current price of $0.00 — trading 99.4% below its estimated fair value. The current Equity-to-Asset is -0.28. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Cannabist Company Holdings (CBSTQ), the current Equity-to-Asset is -0.28 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cannabist Company Holdings Business Description

Address 321 Billerica Road, Suite 204, Chelmsford, MA, USA, 01824
Cannabist Company Holdings Inc through its subsidiaries, operates as a cultivator, manufacturer, and provider of medical and adult-use cannabis products. Some of its products are vaporization oil, sublingual tinctures, lotions, hard-pressed tablets, and suppositories, among others which are marketed through brands like Classix, dreamt, Triple Seven, Amber, Press, Heady, and Seed and Strain. The company operates its businesses in California, Colorado, Delaware, Illinois, Maryland, Massachusetts, New Jersey, New York, Ohio, Pennsylvania, Virginia, and West Virginia.